OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
-17.38%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$37.2M
AUM Growth
+$37.2M
(-11%)
Cap. Flow
+$1.62M
Cap. Flow
% of AUM
4.34%
Top 10 Holdings %
Top 10 Hldgs %
68.93%
Holding
49
New
2
Increased
9
Reduced
21
Closed
10
Top Buys
| 1 |
iShares Biotechnology ETF
IBB
|
$12.1M |
| 2 |
Direxion Daily S&P Biotech Bull 3X Shares
LABU
|
$2.28M |
| 3 |
Exelixis
EXEL
|
$102K |
| 4 |
BLUE
bluebird bio
BLUE
|
$78.2K |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$55.1K |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$3.68M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.42M |
| 3 |
MEI Pharma
MEIP
|
$1.55M |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$1.14M |
| 5 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$891K |
Sector Composition
| 1 | Healthcare | 61.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Biotechnology ETF
IBB
$5.6B
| $12.1M | 26.53% | +125,000 | New | +$12.1M |
|
|
2
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$647M
| $2.28M | 5.01% | +69,309 | New | +$2.28M |
|
3
ProQR Therapeutics
PRQR
$237M
| $2.19M | 4.81% | 138,461 | – | – |
|
4
Mettler-Toledo International
MTD
$26.8B
| $1.83M | 4.03% | 3,235 | – | – |
|
5
Illumina
ILMN
$15.8B
| $1.47M | 3.24% | 4,908 -64 | -1% | -$19.2K |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $1.44M | 3.16% | 8,664 -63 | -0.7% | -$10.4K |
|
7
Ionis Pharmaceuticals
IONS
$6.79B
| $1.21M | 2.65% | 22,307 -986 | -4% | -$53.3K |
|
8
Qiagen
QGEN
$10.1B
| $1.08M | 2.39% | 31,463 -157 | -0.5% | -$5.41K |
|
|
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.08M | 2.39% | 19,127 -161 | -0.8% | -$9.12K |
|
|
10
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.04M | 2.29% | 14,255 +756 | +6% | +$55.1K |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.02M | 2.25% | 10,487 -2,360 | -18% | -$230K |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $940K | 2.07% | 2,516 -15 | -0.6% | -$5.6K |
|
|
LOXO
13
DELISTED
Loxo Oncology, Inc
LOXO
| $870K | 1.91% | 6,210 | – | – |
|
14
BioMarin Pharmaceuticals
BMRN
$11.2B
| $826K | 1.82% | 9,698 -156 | -2% | -$13.3K |
|
15
Incyte
INCY
$16.5B
| $776K | 1.71% | 12,205 -140 | -1% | -$8.9K |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $640K | 1.41% | 9,983 +236 | +2% | +$15.1K |
|
17
Pacira BioSciences
PCRX
$1.2B
| $484K | 1.07% | 11,250 | – | – |
|
18
Nektar Therapeutics
NKTR
$568M
| $435K | 0.96% | 13,223 +1,420 | +12% | +$46.7K |
|
|
19
Exelixis
EXEL
$10.1B
| $426K | 0.94% | 21,646 +5,171 | +31% | +$102K |
|
|
ICPT
20
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $356K | 0.78% | 3,534 -464 | -12% | -$46.7K |
|
21
Amgen
AMGN
$155B
| $328K | 0.72% | 1,685 -156 | -8% | -$30.4K |
|
22
Biogen
BIIB
$19.4B
| $320K | 0.7% | 1,062 +30 | +3% | +$9.04K |
|
23
Grifois
GRFS
$6.78B
| $315K | 0.69% | 17,176 +731 | +4% | +$13.4K |
|
24
FibroGen
FGEN
$47.8M
| $310K | 0.68% | 6,691 -10,447 | -61% | -$484K |
|
25
IQVIA
IQV
$32.4B
| $307K | 0.68% | 2,643 -513 | -16% | -$59.6K |
|